<DOC>
	<DOC>NCT01522716</DOC>
	<brief_summary>The aim of the study is to evaluate the safety and efficacy of mesenchymal stromal cells as treatment for steroid-refractory chronic graft-versus-host disease.</brief_summary>
	<brief_title>Mesenchymal Stromal Cells as Treatment of Chronic Graft-versus-host Disease</brief_title>
	<detailed_description />
	<mesh_term>Graft vs Host Disease</mesh_term>
	<criteria>Chronic graftversushost disease, grade moderate or severe despite at least 3 months treatment with calcineurin inhibitors and steroids OR Chronic graftversushost disease, grade moderate or severe, where full treatment with calcineurin inhibitors and steroids is impossible due to intolerable sideeffects Active malignancy Fulfilling criteria for previously initiated study for treatment of chronic graftversushost disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>